Imetelstat Sodium in Treating Participants With Primary or Secondary Myelofibrosis
NCT01731951
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
80
Enrollment
INDUSTRY
Sponsor class
Conditions
Primary Myelofibrosis
Secondary Myelofibrosis
Myeloid Malignancies
Interventions
DRUG:
Imetelstat
Sponsor
Geron Corporation